NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentationPRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- ...

PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The Company has initiated a pivotal clinical trial to advance its ...